- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 277/44 - Acylated amino or imino radicals
Patent holdings for IPC class C07D 277/44
Total number of patents in this class: 83
10-year publication summary
|
4
|
7
|
4
|
3
|
4
|
2
|
2
|
6
|
3
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20534 |
6 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
5 |
| Stemsynergy Therapeutics, Inc. | 20 |
4 |
| Glaxo Group Limited | 4356 |
3 |
| Syngenta Participations AG | 1588 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 772 |
2 |
| The Johns Hopkins University | 5819 |
2 |
| Adeka Corporation | 1369 |
2 |
| Nihon Nohyaku Co., Ltd. | 325 |
2 |
| Nippon Soda Co., Ltd. | 884 |
2 |
| Anima Biotech Inc. | 38 |
2 |
| Shanghai Yao Yuan Biotechnology Co., Ltd. | 32 |
2 |
| Novartis AG | 10346 |
1 |
| Bristol-myers Squibb Company | 4812 |
1 |
| Genentech, Inc. | 4065 |
1 |
| Massachusetts Institute of Technology | 10196 |
1 |
| DSM IP Assets B.V. | 5429 |
1 |
| Abbvie Inc. | 1843 |
1 |
| Takeda Pharmaceutical Company Limited | 2718 |
1 |
| Vertex Pharmaceuticals Incorporated | 1600 |
1 |
| Other owners | 40 |